Invivyd, Inc. (IVVD)
Largest Insider Buys in Sector
IVVD Stock Price History Chart
IVVD Stock Performance
About Invivyd, Inc.
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research …
Insider Activity of Invivyd, Inc.
Over the last 12 months, insiders at Invivyd, Inc. have bought $0 and sold $20.48M worth of Invivyd, Inc. stock.
On average, over the past 5 years, insiders at Invivyd, Inc. have bought $0 and sold $20.48M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
List of Insider Buy and Sell Transactions, Invivyd, Inc.
| 2024-12-19 | Sale | director | 152,067 0.1277% | $0.43 | $65,951 | -2.67% | ||
| 2024-12-18 | Sale | director | 74,764 0.066% | $0.47 | $35,087 | -10.06% | ||
| 2024-12-17 | Sale | director | 97,410 0.0782% | $0.48 | $46,757 | -9.41% | ||
| 2024-12-16 | Sale | director | 65,359 0.0553% | $0.47 | $30,510 | +3.65% | ||
| 2024-12-12 | Sale | director | 125,000 0.1041% | $0.58 | $72,875 | -18.91% | ||
| 2024-12-11 | Sale | director | 160,400 0.135% | $0.59 | $94,812 | -16.10% | ||
| 2024-12-10 | Sale | director | 175,000 0.1459% | $0.59 | $103,005 | -13.58% | ||
| 2024-12-09 | Sale | director | 150,000 0.1261% | $0.61 | $91,560 | -7.29% | ||
| 2024-05-29 | Sale | director | 112,381 0.2233% | $1.66 | $186,575 | -39.29% | ||
| 2024-01-19 | Sale | 10 percent owner | 5M 23.6347% | $3.95 | $19.75M | -73.62% |